Sunzen Biotech Berhad (KLSE:SUNZEN) executed a non-binding Term Sheet to acquire 70% stake in Eye Nation Medical Sdn.Bhd from Mr. Lee Peng Hwa and Madam Lay Lee Chin for MYR 6.37 million on May 6, 2024. The consideration was paid in cash for common equity of 70000 shares. The acquisition is subject to completion of due diligence.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.38 MYR | -1.30% | +5.56% | +26.67% |
1st Jan change | Capi. | |
---|---|---|
+26.67% | 57.19M | |
-6.04% | 264B | |
-6.71% | 90.64B | |
-5.22% | 42.56B | |
+0.17% | 41.13B | |
+5.99% | 39.96B | |
+2.36% | 37.64B | |
-15.69% | 30.11B | |
-6.51% | 28.41B | |
+12.25% | 25.17B |
- Stock Market
- Equities
- SUNZEN Stock
- News Sunzen Biotech
- Sunzen Biotech Berhad executed a non-binding Term Sheet to acquire 70% stake in Eye Nation Medical Sdn.Bhd from Mr. Lee Peng Hwa and Madam Lay Lee Chin for MYR 6.37 million